1. Home
  2. LGND vs KAR Comparison

LGND vs KAR Comparison

Compare LGND & KAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • KAR
  • Stock Information
  • Founded
  • LGND 1987
  • KAR 2006
  • Country
  • LGND United States
  • KAR United States
  • Employees
  • LGND 68
  • KAR N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • KAR Retail-Auto Dealers and Gas Stations
  • Sector
  • LGND Health Care
  • KAR Consumer Discretionary
  • Exchange
  • LGND Nasdaq
  • KAR Nasdaq
  • Market Cap
  • LGND 2.2B
  • KAR 2.6B
  • IPO Year
  • LGND 1992
  • KAR 2009
  • Fundamental
  • Price
  • LGND $147.40
  • KAR $28.01
  • Analyst Decision
  • LGND Strong Buy
  • KAR Hold
  • Analyst Count
  • LGND 8
  • KAR 5
  • Target Price
  • LGND $144.71
  • KAR $25.20
  • AVG Volume (30 Days)
  • LGND 139.7K
  • KAR 964.5K
  • Earning Date
  • LGND 08-05-2025
  • KAR 08-06-2025
  • Dividend Yield
  • LGND N/A
  • KAR N/A
  • EPS Growth
  • LGND N/A
  • KAR 697.19
  • EPS
  • LGND N/A
  • KAR 0.73
  • Revenue
  • LGND $181,488,000.00
  • KAR $1,856,600,000.00
  • Revenue This Year
  • LGND $18.41
  • KAR $2.04
  • Revenue Next Year
  • LGND $18.87
  • KAR $6.30
  • P/E Ratio
  • LGND N/A
  • KAR $66.85
  • Revenue Growth
  • LGND 53.40
  • KAR 7.20
  • 52 Week Low
  • LGND $81.74
  • KAR $15.44
  • 52 Week High
  • LGND $129.90
  • KAR $29.13
  • Technical
  • Relative Strength Index (RSI)
  • LGND 68.73
  • KAR 70.40
  • Support Level
  • LGND $132.21
  • KAR $24.10
  • Resistance Level
  • LGND $149.21
  • KAR $29.13
  • Average True Range (ATR)
  • LGND 5.37
  • KAR 0.73
  • MACD
  • LGND 0.53
  • KAR 0.32
  • Stochastic Oscillator
  • LGND 83.70
  • KAR 78.93

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About KAR OPENLANE Inc.

Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.

Share on Social Networks: